CIAM
NVO

Caitong International Asset Management’s Novo Nordisk NVO Stock Holding History

Caitong International Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,978
Closed -$101K – 2909
2025
Q4 		$101K Sell
1,978
-2,400
-55% -$123K 0.02% 422
2025
Q3 		$243K Buy
+4,378
New +$256K 0.17% 64
2025
Q1 		– Sell
-6
Closed -$516 – 2421
2024
Q4 		$516 Buy
+6
New +$649 ﹤0.01% 1455

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Caitong International Asset Management's NVO Position: Q1 2026 in Review

Caitong International Asset Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 1,978 shares — an estimated $101K sold.

Caitong International Asset Management first reported a position in NVO in Q4 2024 and held it in 3 quarters. The position peaked at $243K in Q3 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Caitong International Asset Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1,978 Novo Nordisk shares in Q1 2026, an estimated $101K.
  • Caitong International Asset Management first reported a position in Novo Nordisk in Q4 2024 and held it in 3 quarters.
  • Caitong International Asset Management's Novo Nordisk position peaked at $243K in Q3 2025.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.